Document is current
Any future updates will be listed below
-
Authors
Claesson, Tor-björn
Mutter, Stefan
Putaala, Jukka
Salli, Eero
Gordin, Daniel
Groop, Per-Henrik
Martola, Juha
Thorn, Lena M.
-
Funding
Funding for this research was provided by:
University of Helsinki
- License Information
-
More Information
Article History
Received: 27 May 2024
Accepted: 5 February 2025
First Online: 18 February 2025
Declarations
:
: All study participants gave written informed consents, and the study was approved by the Ethics Committee of the Helsinki and Uusimaa Hospital District (HUS/3313/2018 and HUS/2184/2017). The study was performed in accordance with the Declaration of Helsinki.
: Not applicable.
: S.M. received lecture honoraria from Encore Medical Education.D.G. Astellas, AstraZeneca, Bayer, Boehringer Ingelheim, Fresenius, GE Healthcare, Harald AI, Novo Nordisk, Ratiopharm.P-H.G. has received lecture honoraria from Astellas, AstraZeneca, Bayer, Boehringer Ingelheim, Eli Lilly, Elo Water, Genzyme, Medscape, MSD, Novartis, Novo Nordisk, Sanofi, Sciarc, and he is an advisory board member of AbbVie, Astellas, AstraZeneca, Bayer, Boehringer Ingelheim, Eli Lilly, Janssen, Medscape, MSD, Nestlé, Novartis, Novo Nordisk, and Sanofi. J.M. has received lecture honoraria from Santen.The other authors declare no conflict of interest.
: Not applicable.
